发明名称 Delayed-release (pH or enzymatically triggered) dosage forms of sertraline
摘要 <p>Sertraline is a selective serotonin reuptake inhibitor (SSRI), which is useful as an antidepressant and anorectic agent, and in the treatment of obsessive-compulsive disorder, post-traumatic stress disorder, anxiety-related disorders and panic. Delayed-release dosage forms of sertraline, which reduce Tmax and side effects, are described. The dosage forms are, in general, spatially delayed by being sensitive to their position along the gastrointestinal tract, or temporally delayed by being delayed for a preset period, independent of their position along the gastrointestinal tract. In vitro tests for identifying such dosage forms are presented.</p>
申请公布号 NZ501249(A) 申请公布日期 2001.06.29
申请号 NZ19980501249 申请日期 1998.06.16
申请人 PFIZER PRODUCTS INC 发明人 CURATOLO, WILLIAM JOHN;FRIEDMAN, HYLAR LEWIS
分类号 A61K9/14;A61K;A61K9/20;A61K9/22;A61K9/28;A61K9/32;A61K9/50;A61K9/52;A61K31/135;A61K31/136;A61K47/32;A61K47/38;A61P3/04;A61P15/00;A61P25/00;A61P25/30;(IPC1-7):A61K31/135 主分类号 A61K9/14
代理机构 代理人
主权项
地址